Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
The New England Journal of Medicine
|
September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic Syndrome
Eric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Advances
|
October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma
Erica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Journal for Immunotherapy of Cancer
|
November 3, 2024
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
Kevin C Flanagan, Jon Earls, Jeffrey Hiken, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
December 5, 2013
Clinical genomicist workstation
Mukesh K Sharma, Joshua Phillips, Saurabh Agarwal, et al.
The Journal of Molecular Diagnostics : JMD
|
November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncology
Catherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
JAMA
|
August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
Jeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Journal of Cancer Research and Clinical Oncology
|
August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
The New England Journal of Medicine
|
September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic Syndrome
Eric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Advances
|
October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma
Erica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Journal for Immunotherapy of Cancer
|
November 3, 2024
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study
Kevin C Flanagan, Jon Earls, Jeffrey Hiken, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
December 5, 2013
Clinical genomicist workstation
Mukesh K Sharma, Joshua Phillips, Saurabh Agarwal, et al.
The Journal of Molecular Diagnostics : JMD
|
November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncology
Catherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
JAMA
|
August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
Jeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Journal of Cancer Research and Clinical Oncology
|
August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
Blood
|
September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.
Page
of 11